A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors

NCT07300150 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

195

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer
Pancreatic Cancer
Non-Small Cell Lung Cancer
Solid Tumor

Interventions

DRUG: PT0511
DRUG: Cetuximab

Sponsor

PAQ Therapeutics, Inc.